Catalyst Wire Dossier Catalyst Wire Dossier

Akynzeo

netupitant/palonosetron · Helsinn Healthcare S.A.
Drug timelines are a Plus or Pro feature.

23 regulatory and trial events tracked for Akynzeo, covering 2014-10-10 to 2026-08-25. Get the full timeline:

Most recent: EMA Authorised: Akynzeo (netupitant;palonosetron hydrochloride) — Helsinn Birex Pharmaceuticals Ltd

See pricing